Generic Name and Formulations:
Dexamethasone 0.1%; oph susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for MAXIDEX:
Adults and Children:
Instill 1–2 drops in the affected eye(s). Severe: may administer hourly, then taper as condition improves. Mild: may administer up to 4–6 times daily.
Acute, untreated bacterial, fungal, mycobacterial, epithelial herpes simplex, or viral (except herpes zoster) infections of the eye.
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure if used for ≥10 days. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Local irritation, ocular discomfort, increased intraocular pressure, cataracts, corneal perforations, optic nerve damage; may mask or exacerbate infections.
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients
- Changes in Renal Cell Carcinoma Pathologic Staging and Histologic Grading
- Nocturia, Overactive Bladder Improved With PTNS
- Many Americans Unaware of Promise of Personalized Medicine
- Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk
- VDRAs Do Not Lower Cardiovascular Event Risk in HD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)